Upstream mitogen-activated protein kinase (MAPK)pathway inhibition: MEK inhibitor followed by a BRAF inhibitor in advanced melanoma patients - Goldinger, Simone M.; Schulz, Carsten; Hassel, Jessica C. (European journal of cancer, 2014)
Gesehen am 08.10.2014